Royalty Pharma PLC

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Royalty Pharma PLC had 586.39M in cash and cash equivalents.

Royalty Pharma PLC reported 9.91B in total liabilities as of the latest reported quarter, including 636.21M in current liabilities and 9.27B in non-current liabilities.

As of the latest reported quarter, Royalty Pharma PLC's total assets were 19.62B, consisting of 1.53B in current assets and 18.09B in non-current assets.

Royalty Pharma PLC reported 9.71B in total shareholders' equity as of the latest reported quarter.